Literature DB >> 8918470

Reconstitution of human telomerase activity and identification of a minimal functional region of the human telomerase RNA.

C Autexier1, R Pruzan, W D Funk, C W Greider.   

Abstract

Telomerase is a ribonucleoprotein that catalyzes telomere elongation through the addition of TTAGGG repeats in humans. Activation of telomerase is often associated with immortalization of human cells and cancer. To dissect the human telomerase enzyme mechanism, we developed a functional in vitro reconstitution assay. After removal of the essential 445 nucleotide human telomerase RNA (hTR) by micrococcal nuclease digestion of partially purified human telomerase, the addition of in vitro transcribed hTR reconstituted telomerase activity. The activity was dependent upon and specific to hTR. Using this assay, truncations at the 5' and 3' ends of hTR identified a functional region of hTR, similar in size to the full-length telomerase RNAs from ciliates. This region is located between positions 1-203. Furthermore, we found that residues 1-44, 5' to the template region (residues 46-56) are not essential for activity, indicating a minimal functional region is located between residues 44-203. Mutagenesis of full-length hTR between residues 170-179, 180-189 or 190-199 almost completely abolished the ability of the hTR to function in the reconstitution of telomerase activity, suggesting that sequences or structures within this 30 nucleotide region are required for activity, perhaps by binding telomerase protein components.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8918470      PMCID: PMC452365     

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism?

Authors:  W E Wright; J W Shay
Journal:  Trends Cell Biol       Date:  1995-08       Impact factor: 20.808

2.  In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs.

Authors:  G L Yu; J D Bradley; L D Attardi; E H Blackburn
Journal:  Nature       Date:  1990-03-08       Impact factor: 49.962

Review 3.  The assembly of prokaryotic ribosomes.

Authors:  K H Nierhaus
Journal:  Biochimie       Date:  1991-06       Impact factor: 4.079

4.  Functional characterization and developmental regulation of mouse telomerase RNA.

Authors:  M A Blasco; W Funk; B Villeponteau; C W Greider
Journal:  Science       Date:  1995-09-01       Impact factor: 47.728

5.  Boundary elements of the Tetrahymena telomerase RNA template and alignment domains.

Authors:  C Autexier; C W Greider
Journal:  Genes Dev       Date:  1995-09-15       Impact factor: 11.361

6.  Runaway telomere elongation caused by telomerase RNA gene mutations.

Authors:  M J McEachern; E H Blackburn
Journal:  Nature       Date:  1995-08-03       Impact factor: 49.962

7.  Method for determining RNA 3' ends and application to human telomerase RNA.

Authors:  A J Zaug; J Linger; T R Cech
Journal:  Nucleic Acids Res       Date:  1996-02-01       Impact factor: 16.971

8.  U2 RNA from yeast is unexpectedly large and contains homology to vertebrate U4, U5, and U6 small nuclear RNAs.

Authors:  M Ares
Journal:  Cell       Date:  1986-10-10       Impact factor: 41.582

9.  Telomeres shorten during ageing of human fibroblasts.

Authors:  C B Harley; A B Futcher; C W Greider
Journal:  Nature       Date:  1990-05-31       Impact factor: 49.962

10.  Telomere length predicts replicative capacity of human fibroblasts.

Authors:  R C Allsopp; H Vaziri; C Patterson; S Goldstein; E V Younglai; A B Futcher; C W Greider; C B Harley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  59 in total

1.  Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro.

Authors:  V M Tesmer; L P Ford; S E Holt; B C Frank; X Yi; D L Aisner; M Ouellette; J W Shay; W E Wright
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

2.  Interference footprinting analysis of telomerase elongation complexes.

Authors:  S Benjamin; N Baran; H Manor
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

3.  Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding.

Authors:  T L Beattie; W Zhou; M O Robinson; L Harrington
Journal:  Mol Biol Cell       Date:  2000-10       Impact factor: 4.138

Review 4.  Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin.

Authors:  Michael P Terns; Rebecca M Terns
Journal:  Gene Expr       Date:  2002

5.  Analysis of the structure of human telomerase RNA in vivo.

Authors:  Mária Antal; Eva Boros; Ferenc Solymosy; Tamás Kiss
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

6.  Expression of hTERT and hTR in cis reconstitutes and active human telomerase ribonucleoprotein.

Authors:  F Bachand; G Kukolj; C Autexier
Journal:  RNA       Date:  2000-05       Impact factor: 4.942

7.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

8.  Comprehensive structure-function analysis of the core domain of human telomerase RNA.

Authors:  Hinh Ly; Elizabeth H Blackburn; Tristram G Parslow
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  Solution structure and dynamics of the wild-type pseudoknot of human telomerase RNA.

Authors:  Nak-Kyoon Kim; Qi Zhang; Jing Zhou; Carla A Theimer; Robert D Peterson; Juli Feigon
Journal:  J Mol Biol       Date:  2008-10-11       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.